Loading...
•
Jun 30, 2022
AptarGroup Q2 2022 Earnings Report
Reported a strong quarter with sales and net income increasing, driven by core sales growth and pricing initiatives.
Key Takeaways
AptarGroup reported a positive second quarter with a 4% increase in reported sales and a 15% increase in net income. Core sales grew by 10%, and adjusted EBITDA increased by 8%. The company is focused on pricing initiatives and managing expenses to drive shareholder return.
Reported sales grew 4% and net income increased 15% to $64 million.
Core sales increased 10% and adjusted EBITDA increased 8% to $160 million.
Reported earnings per share increased 17% to $0.95 compared to $0.81 in the prior year.
Each segment achieved sales growth through improved volume as well as increased pricing, with Pharma and Beauty + Home segments reaching double-digit core sales growth.
AptarGroup
AptarGroup
AptarGroup Revenue by Segment
Revenue by Segment
Aptar Pharma Revenue
CapyFin.comAptar Beauty Revenue
CapyFin.comAptar Closures Revenue
CapyFin.com Forward Guidance
Aptar expects earnings per share for the third quarter of 2022, excluding any restructuring expenses, changes in the fair value of equity investments and acquisition costs, to be in the range of $0.90 to $1.00.
Positive Outlook
- Pharma segment’s prescription drug and consumer health care markets are expected to continue strong momentum in the coming quarter.
- Well positioned to navigate a potential economic downturn due to the strength of our balance sheet
- Disciplined approach to capital management
- Broad portfolio of innovative solutions
- Serve multiple essential markets
Challenges Ahead
- Rising inflation
- Ongoing war in Ukraine
- Supply chain disruptions
- Very tight U.S. labor market
- The stronger dollar is expected to continue to have an impact on our results.
Revenue & Expenses
Visualization of income flow from segment revenue to net income